CoChat
Sign Up
Cited by 55

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction

Blázquez-Prunera, Arantxa, Díez, José María, Gajardo, Rodrigo, Grancha, Salvador·2017·Stem Cell Research & Therapy
DOI 10.1186/s13287-017-0552-zPMC PMC5408419
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-017-0552-z

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acceptable intervals for periodic testing to confirm the genetic and phenotypic stability of the cell system can be highly case-dependent.

    “It is recommended to develop acceptable intervals for periodic testing to confirm the genetic and phenotypic stability of the cell system; these, however, can be highly case-dependent (Blazquez-Prunera et al., 2017; Daily et al., 2017; Meza-Zepeda et al., 2008).”

    From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Blazquez-Prunera et al., 2017

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 47

  1. [1]Singer NG Caplan AI Mesenchymal stem cells: mechanisms of inflammation Annu Rev Pathol. 2011 6 457 78 10.1146/annurev-pathol-011110-130230 21073342 · DOI
  2. [2]Horwitz EM Le Blanc K Dominici M Mueller I Slaper-Cortenbach I Marini FC Deans RJ Krause DS Keating A International Society for Cellular Therapy Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement Cytotherapy. 2005 7 393 5 10.1080/14653240500319234 16236628 · DOI
  3. [3]Singec I Janrial R Crain A Nikkhah G Snyder EY The leading edge of stem cell therapeutics Annu Rev Med. 2007 58 313 28 10.1146/annurev.med.58.070605.115252 17100553 · DOI
  4. [5]Aldahmash A Haack-Sørensen M Al-Nbaheen M Harkness L Abdallah BM Kassem M Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo Stem Cell Rev. 2011 7 860 8 10.1007/s12015-011-9274-2 21603946 · DOI
  5. [6]Bieback K Hecker A Kocaömer A Lannert H Schallmoser K Strunk D Klüter H Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow Stem Cells. 2009 27 2331 41 10.1002/stem.139 19544413 · DOI
  6. [7]Spees JL Gregory CA Singh H Tucker HA Peister A Lynch PJ Hsu SC Smith J Prockop DJ Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy Mol Ther. 2004 9 747 56 10.1016/j.ymthe.2004.02.012 15120336 · DOI
  7. [8]Jayme DW Smith SR Media formulation options and manufacturing process controls to safeguard against introduction of animal origin contaminants in animal cell culture Cytotechnology. 2000 33 27 36 10.1023/A:1008133717035 19002808 PMC3466725 · DOI
  8. [9]Jung S Panchalingam KM Rosenberg L Behie LA Ex vivo expansion of human mesenchymal stem cells in defined serum-free media Stem Cells Int. 2012 2012 123030 10.1155/2012/123030 22645619 PMC3356989 · DOI
  9. [11]Lennon DP Haynesworth SE Young RG Dennis JE Caplan AI A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells Exp Cell Res. 1995 1 211 22 10.1006/excr.1995.1221 7628536 · DOI
  10. [12]Parker AM Shang H Khurgel M Katz A Low serum and serum-free culture of multipotential human adipose stem cells Cytotherapy. 2007 9 637 46 10.1080/14653240701508452 17917877 · DOI
  11. [13]Lindroos B Boucher S Chase L Kuokkanen H Huhtala H Haataja R Vemuri M Suuronen R Miettinen S Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro Cytotherapy. 2009 11 958 72 10.3109/14653240903233081 19903107 · DOI
  12. [14]Miwa H Hashimoto Y Tensho K Wakitani S Takagi M Xeno-free proliferation of human bone marrow mesenchymal stem cells Cytotechnology. 2012 64 301 8 10.1007/s10616-011-9400-7 22002865 PMC3386392 · DOI
  13. [15]Schallmoser K Rohde E Reinisch A Bartmann C Thaler D Drexler C Obenauf AC Lanzer G Linkesch W Strunk D Rapid largescale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum Tissue Eng Part C Methods. 2008 14 185 96 10.1089/ten.tec.2008.0060 18620484 · DOI
  14. [16]Liu CH Wu ML Hwang SM Optimization of serum free medium for cord blood mesenchymal stem cells Biochem Eng J. 2007 33 1 9 10.1016/j.bej.2006.08.005 · DOI
  15. [17]Hartmann I Hollweck T Haffner S Krebs M Meiser B Reichart B Eissner G Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties J Immunol Methods. 2010 363 80 9 10.1016/j.jim.2010.10.008 21035451 · DOI
  16. [18]Oikonomopoulos A van Deen WK Manansala AR Lacey PN Tomakili TA Ziman A Hommes DW Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media Sci Rep. 2015 5 16570 10.1038/srep16570 26564250 PMC4643287 · DOI
  17. [19]Chase LG Yang S Zachar V Yang Z Lakshmipathy U Bradford J Boucher SE Vemuri MC Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells Stem Cells Transl Med. 2012 1 750 8 10.5966/sctm.2012-0072 23197667 PMC3659659 · DOI
  18. [20]Corotchi MC Popa MA Remes A Sima LE Gussi I Lupu PM Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells Stem Cell Res Ther. 2013 4 81 10.1186/scrt232 23845279 PMC3854854 · DOI
  19. [21]Patrikoski M Juntunen M Boucher S Campbell A Vemuri MC Mannerström B Miettinen S Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells Stem Cell Res Ther. 2013 4 27 10.1186/scrt175 23497764 PMC3707027 · DOI
  20. [22]Simoes IN Boura JS Dos Santos F Andrade PZ Cardoso CM Gimble JM da Silva CL Cabral JM Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex-vivo expansion using serum-/xeno-free culture media Biotechnol J. 2013 8 448 58 10.1002/biot.201200340 23420807 · DOI
  21. [23]Gstraunthaler G Alternatives to the use of fetal bovine serum: serum-free cell culture ALTEX. 2003 20 275 81 14671707
  22. [24]Li CY Wu XY Tong JB Yang XX Zhao JL Zheng QF Zhao GB Ma ZJ Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy Stem Cell Res Ther. 2015 13 6 55 PMC4453294 25884704
  23. [25]Doucet C Ernou I Zhang Y Llense JR Begot L Holy X Lataillade JJ Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications J Cell Physiol. 2005 205 228 36 10.1002/jcp.20391 15887229 · DOI
  24. [26]Schallmoser K Bartmann C Rohde E Reinisch A Kashofer K Stadelmeyer E Drexler C Lanzer G Linkesch W Strunk D Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells Transfusion. 2007 47 1436 46 10.1111/j.1537-2995.2007.01220.x 17655588 · DOI
  25. [27]Cohn EJ Strong LE Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids J Am Chem Soc. 1946 68 459 75 10.1021/ja01207a034 21015743 · DOI
  26. [28]Lange C Cakiroglu F Spiess AN Cappallo-Obermann H Dierlamm J Zander AR Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine J Cell Physiol. 2007 213 18 26 10.1002/jcp.21081 17458897 · DOI
  27. [29]Díez JM Bauman E Gajardo R Jorquera JI Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools Stem Cell Res Ther. 2015 6 28 10.1186/s13287-015-0016-2 25889980 PMC4396121 · DOI
  28. [30]Blázquez-Prunera A, Almeida CR, Barbosa MA. Human bone marrow mesenchymal stem/stromal cells preserve their immunomodulatory and chemotactic properties when expanded in a human plasma-derived xeno-free medium. Stem Cells International. 2017 (in press). PMC5446864 28588620
  29. [31]Schallmoser K Strunk D Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures J Vis Exp. 2009 32 1523 PMC3164065 19881465
  30. [32]Tunaitis V Borutinskaité V Navakauskiené R Treigytė G Ungurytė A Aldonytė R Magnusson KE Pivoriūnas A Effects of different sera on adipose tissue-derived mesenchymal stromal cells J Tissue Eng Regen Med. 2011 5 733 46 10.1002/term.374 21953871 · DOI
  31. [33]Dahl JA Duggal S Coulston N Millar D Melki J Shahdadfar A Brinchmann JE Collas P Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fatal bovine serum Int J Dev Biol. 2008 52 1033 42 10.1387/ijdb.082663jd 18956336 · DOI
  32. [34]Mizuno N Shiba H Ozeki Y Mouri Y Niitani M Inui T Hayashi H Suzuki K Tanaka S Kawaguchi H Kurihara H Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures Cell Biol Int. 2006 30 521 4 10.1016/j.cellbi.2006.01.010 16616867 · DOI
  33. [35]Stute N Holtz K Bubenheim M Lange C Blake F Zander AR Autologous serum for isolation and expansion of human mesenchymal stemcells for clinical use Exp Hematol. 2004 32 1212 25 10.1016/j.exphem.2004.09.003 15588946 · DOI
  34. [36]Shahdadfar A Frønsdal K Haug T Reinholt FP Brinchmann JE In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability Stem Cells. 2005 23 1357 66 10.1634/stemcells.2005-0094 16081661 · DOI
  35. [37]Tateishi K Ando W Higuchi C Hart DA Hashimoto J Nakata K Yoshikawa H Nakamura N Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications Cell Transplant. 2008 17 549 57 10.3727/096368908785096024 18714674 · DOI
  36. [38]Kuznetsov SA Mankani MH Robey PG Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation Transplantation. 2000 70 1780 7 10.1097/00007890-200012270-00018 11152111 · DOI
  37. [39]Poloni A Maurizi G Rosini V Mondini E Mancini S Discepoli G Biasio S Battaglini G Felicetti S Berardinelli E Serrani F Leoni P Selection of CD271+ cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow Cytotherapy. 2009 11 153 62 10.1080/14653240802582125 19301169 · DOI
  38. [40]Le Blanc K Samuelsson H Lönnies L Sundin M Ringdén O Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum Transplantation. 2007 84 1055 9 10.1097/01.tp.0000285088.44901.ea 17989613 · DOI
  39. [41]Kocaoemer A Kern S Kluter H Bieback K Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue Stem Cells. 2007 25 1270 8 10.1634/stemcells.2006-0627 17255520 · DOI
  40. [42]Dominici M Le Blanc K Mueller I Slaper-Cortenbach I Marini F Krause D Deans R Keating A Prockop DJ Horwitz E Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy. 2006 8 315 7 10.1080/14653240600855905 16923606 · DOI · Paper page
  41. [43]Zeddou M Relic B Malaise MG Umbilical cord fibroblasts: Could they be considered as mesenchymal stem cells? World J Stem Cells. 2014 6 367 70 10.4252/wjsc.v6.i3.367 25126385 PMC4131277 · DOI
  42. [44]Nagamura-Inoue T He H Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility World J Stem Cells. 2014 6 195 202 10.4252/wjsc.v6.i2.195 24772246 PMC3999777 · DOI
  43. [45]Lohmann M Walenda G Hemeda H Joussen S Drescher W Jockenhoevel S Hutschenreuter G Zenke M Wagner W Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells Plos One. 2012 7 10.1371/journal.pone.0037839 22662236 PMC3360602 · DOI
  44. [46]Lange C Brunswig-Spickenheier B Eissing L Scheja L Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells Exp Cell Res. 2012 318 2284 96 10.1016/j.yexcr.2012.06.004 22698646 · DOI
  45. [47]Gruber R Karreth F Kandler B Fuerst G Rot A Fischer MB Watzek G Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions Platelets. 2004 15 29 35 10.1080/09537100310001643999 14985174 · DOI
  46. [48]Abdelrazik H Spaggiari GM Chiossone L Moretta L Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function Eur J Immunol. 2011 41 3281 90 10.1002/eji.201141542 21874650 · DOI
  47. [49]Copland IB Garcia MA Waller EK Roback JD Galipeau J The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy Biomaterials. 2013 34 7840 50 10.1016/j.biomaterials.2013.06.050 23891515 · DOI

Cited by

Sorted by citations

Authors
Blázquez-Prunera, A., Díez, J. M., Gajardo, R., & Grancha, S.
Venue
Stem Cell Research & Therapy
Publisher
Springer Science and Business Media LLC
Published
2017-04-27
Volume
8
Issue
1
ISSN
1757-6512
DOI
10.1186/s13287-017-0552-z
PMC
PMC5408419
Cited by
55
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review